Lexicon Pharmaceuticals Inc.

(LXRX) Trade

By |

Profile

Lexicon Pharmaceuticals Inc is a biopharmaceutical company developing medicines that transform patients' lives. The company commercializes and develops drugs and drug candidates. Its drugs candidates include XERMELO (telotristat ethyl), an orally-delivered small molecule drug, in the United States for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog, or SSA, therapy in adults inadequately controlled by SSA therapy; Zynquista (sotagliflozin), an orally-delivered small molecule drug candidate, as a treatment for type 1 diabetes; sotagliflozin as a treatment for type 2 diabetes, heart failure and chronic kidney disease; and LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain.

Contact Information

Website: www.lexpharma.com
Main Phone: +1 281 863-3000
Address: 8800 Technology Forest Place
State: TX
City / Town: The Woodlands
Country: US
Postal Code: 77381

Issuer Information

Exchange: NGS
CEO: Lonnel Coats
Employees: 184
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

Profile

Lexicon Pharmaceuticals Inc is a biopharmaceutical company developing medicines that transform patients' lives. The company commercializes and develops drugs and drug candidates. Its drugs candidates include XERMELO (telotristat ethyl), an orally-delivered small molecule drug, in the United States for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog, or SSA, therapy in adults inadequately controlled by SSA therapy; Zynquista (sotagliflozin), an orally-delivered small molecule drug candidate, as a treatment for type 1 diabetes; sotagliflozin as a treatment for type 2 diabetes, heart failure and chronic kidney disease; and LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain.

Contact Information

Website: www.lexpharma.com
Main Phone: +1 281 863-3000
Address: 8800 Technology Forest Place
State: TX
City / Town: The Woodlands
Country: US
Postal Code: 77381

Issuer Information

Exchange: NGS
CEO: Lonnel Coats
Employees: 184
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

$ 1.62 $ -0.08 (-4.71%)
Last Price 1.62 Change $ -0.08 Change % -4.71 Tick N/A
Bid 1.62 Bid Size 300.00 Ask 1.68 Ask Size 600.00
Open 1.70 High 1.71 Low 1.60 Prev Close 1.70
Last Trade Volume 858,982 52 Wk Hi 5.33 52 Wk Low 1.51
Market Cap 173.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 107,105,853.00 EPS (TTM) 0.24 PE Ratio 6.80 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 23 83
Number of Buys 22 75
Number of Sells 1 8
Net Activity 1432151 2106122
Last 10 Buys Shares
Westend Sa 1,000
Westend Sa 1,000
Westend Sa 1,000
Westend Sa 1,000
Westend Sa 1,000
Westend Sa 1,000
Westend Sa 1,000
Westend Sa 1,000
Westend Sa 1,000
Westend Sa 1,000
Last 10 Sell Shares
James F. Tessmer 1,000
James F. Tessmer 1,000
James F. Tessmer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 42 42 42 42
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 25.5 25.5 25.5 25.5
Standard Deviation 13.53 13.53 13.53 13.53
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 2 2
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.43 2.43 2.67 2.67